Inventory Management Agreements: Challenge in the Channel

Overview:

Recent Inventory Management Agreements (IMAs) between drug manufacturers and wholesalers may have created unintended industry consequences such as increasing the risks and velocity of drug product shortages and imposing additional costs on as hospitals and pharmacies. In this white paper, Pembroke Consulting takes a critical look at the inventory impact of IMAs on companies such as Merck, Pfizer, BMS, and The Big Three drug wholesalers.